Skip Navigation
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer

Association List

[Full Text]
Displaying Investigations 1 to 74 of 74 found
From 19 References


Brennan et al 2013, Cell
  Astrocytoma, grade III-IV/Glioblastoma Brain
FGFR3/TACC3
t(4;4)(p16;p16)

Capelletti et al 2014, Clin Cancer Res
  Adenocarcinoma Lung
FGFR3/TACC3
t(4;4)(p16;p16)

Di Stefano et al 2015, Clin Cancer Res
  Astrocytoma, grade I-II Brain
FGFR3/TACC3
t(4;4)(p16;p16)

Frattini et al 2013, Nat Genet
  Astrocytoma, grade III-IV/Glioblastoma Brain
FGFR3/TACC3
t(4;4)(p16;p16)
  Astrocytoma, grade III-IV/Glioblastoma Brain
TBC1D14/HTRA3
t(4;4)(p16;p16)

Guo et al 2013, Nat Genet
  Transitional cell carcinoma Bladder
FGFR3/TACC3
t(4;4)(p16;p16)

Helsten et al 2016, Clin Cancer Res
  Squamous cell carcinoma Uterus, cervix
FGFR3/TACC3
t(4;4)(p16;p16)
  Adenocarcinoma Uterus, corpus
FGFR3/TACC3
t(4;4)(p16;p16)
  Adenocarcinoma Gallbladder/Biliary system
FGFR3/TACC3
t(4;4)(p16;p16)
  Glioma, NOS Brain
FGFR3/TACC3
t(4;4)(p16;p16)
  Adenocarcinoma Kidney
FGFR3/TACC3
t(4;4)(p16;p16)
  Adenocarcinoma Gallbladder/Biliary system
FGFR2/TACC3
t(4;4)(p16;p16)
  Transitional cell carcinoma Bladder
FGFR3/JAKMIP1
t(4;4)(p16;p16)
  Transitional cell carcinoma Bladder
FGFR3/TNIP2
t(4;4)(p16;p16)
  Adenocarcinoma Breast
FGFR3/WHSC1
t(4;4)(p16;p16)

Hu et al 2018, Nucleic Acids Res
  Adenocarcinoma Uterus, corpus
ADD1/PCGF3
t(4;4)(p16;p16)
  Astrocytoma, grade I-II Brain
CPLX1/GAK
t(4;4)(p16;p16)
  Adenocarcinoma Breast
CTBP1/POLN
t(4;4)(p16;p16)
  Adenocarcinoma Liver
DGKQ/POLN
t(4;4)(p16;p16)
  Astrocytoma, grade I-II Brain
FAM193A/PPP2R2C
t(4;4)(p16;p16)
  Adenocarcinoma Stomach
FAM193A/ZFYVE28
t(4;4)(p16;p16)
  Transitional cell carcinoma Bladder
GAK/SPON2
t(4;4)(p16;p16)
  Adenocarcinoma Stomach
KIAA0232/MRFAP1
t(4;4)(p16;p16)
  Adenocarcinoma Ovary
KIAA0232/MAN2B2
t(4;4)(p16;p16)
  Adenocarcinoma Uterus, corpus
LETM1/MXD4
t(4;4)(p16;p16)
  Adenocarcinoma Liver
NOP14/LYAR
t(4;4)(p16;p16)
  Adenocarcinoma Stomach
PCGF3/HTT
t(4;4)(p16;p16)
  Transitional cell carcinoma Bladder
PCGF3/MYL5
t(4;4)(p16;p16)
  Squamous cell carcinoma Uterus, cervix
PCGF3/PDE6B
t(4;4)(p16;p16)
  Astrocytoma, grade I-II Brain
PPP2R2C/CTBP1
t(4;4)(p16;p16)
  Adenocarcinoma Prostate
SPON2/CTBP1
t(4;4)(p16;p16)
  Malignant melanoma Skin
TACC3/TMEM129
t(4;4)(p16;p16)
  Adenocarcinoma Kidney
TBC1D14/KIAA0232
t(4;4)(p16;p16)
  Acute myeloid leukemia, NOS
UVSSA/MAEA
t(4;4)(p16;p16)
  Astrocytoma, grade I-II Brain
WHSC1/CPLX1
t(4;4)(p16;p16)
  Mesenchymal tumor, NOS Unknown site
ZFYVE28/CRMP1
t(4;4)(p16;p16)

Javle et al 2014, Hum Pathol
  Adenocarcinoma Gallbladder/Biliary system
FGFR3/TACC3
t(4;4)(p16;p16)

Liu et al 2016, EBioMedicine
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
FGFRL1/CTBP1
t(4;4)(p16;p16)
B-Lineage

Shah et al 2013, BMC Genomics
  Astrocytoma, grade III-IV/Glioblastoma Brain
FGFR3/TACC3
t(4;4)(p16;p16)
  Astrocytoma, grade III-IV/Glioblastoma Brain
TBC1D14/HTRA3
t(4;4)(p16;p16)

Singh et al 2012, Science
  Astrocytoma, grade III-IV/Glioblastoma Brain
FGFR3/TACC3
t(4;4)(p16;p16)

Stransky et al 2014, Nat Commun
  Squamous cell carcinoma Lung
FGFR3/TACC3
t(4;4)(p16;p16)
  Adenocarcinoma Kidney
FGFR3/TACC3
t(4;4)(p16;p16)
  Astrocytoma, grade I-II Brain
FGFR3/TACC3
t(4;4)(p16;p16)
  Adenocarcinoma Bladder
FGFR3/TACC3
t(4;4)(p16;p16)

Wen et al 2012, PLoS One
  Acute myeloid leukemia, NOS
ATP5I/MFSD7
t(4;4)(p16;p16)

Williams et al 2013, Hum Mol Genet
  Transitional cell carcinoma Bladder
FGFR3/TACC3
t(4;4)(p16;p16)

Wu et al 2013, Cancer Discov
  Transitional cell carcinoma Bladder
FGFR3/TACC3
t(4;4)(p16;p16)
  Carcinoma, NOS Oral cavity
FGFR3/TACC3
t(4;4)(p16;p16)
  Astrocytoma, grade III-IV/Glioblastoma Brain
FGFR3/TACC3
t(4;4)(p16;p16)
  Squamous cell carcinoma Nasopharynx
FGFR3/TACC3
t(4;4)(p16;p16)
  Squamous cell carcinoma Lung
FGFR3/TACC3
t(4;4)(p16;p16)

Yoshihara et al 2015, Oncogene
  Squamous cell carcinoma Lung
FGFR3/TACC3
t(4;4)(p16;p16)
  Adenocarcinoma Ovary
ADD1/SH3BP2
t(4;4)(p16;p16)
  Adenocarcinoma Ovary
ADD1/FAM193A
t(4;4)(p16;p16)
  Squamous cell carcinoma Lung
FAM193A/TNIP2
t(4;4)(p16;p16)
  Adenocarcinoma Lung
WHSC1/FAM53A
t(4;4)(p16;p16)
  Acute myeloid leukemia, NOS
MAEA/CTBP1
t(4;4)(p16;p16)
  Acute myeloid leukemia, NOS
UVSSA/MAEA
t(4;4)(p16;p16)
  Squamous cell carcinoma Oral cavity
SLBP/LETM1
t(4;4)(p16;p16)
  Adenocarcinoma Breast
AFAP1/ABLIM2
t(4;4)(p16;p16)
  Adenocarcinoma Breast
TBC1D14/EVC
t(4;4)(p16;p16)
  Adenocarcinoma Breast
PCGF3/PIGG
t(4;4)(p16;p16)
  Adenocarcinoma Breast
WHSC1/TACC3
t(4;4)(p16;p16)
  Transitional cell carcinoma Bladder
HTT/GRK4
t(4;4)(p16;p16)
  Transitional cell carcinoma Bladder
SORCS2/SH3TC1
t(4;4)(p16;p16)
  Transitional cell carcinoma Bladder
MAN2B2/TACC3
t(4;4)(p16;p16)
  Transitional cell carcinoma Bladder
ABLIM2/PPP2R2C
t(4;4)(p16;p16)

Yuan et al 2014, Cancer Biol Ther
  Adenocarcinoma Nasopharynx
FGFR3/TACC3
t(4;4)(p16;p16)
  Adenocarcinoma Nasal cavity/Paranasal sinuses
FGFR3/TACC3
t(4;4)(p16;p16)
  Squamous cell carcinoma Oesophagus
FGFR3/TACC3
t(4;4)(p16;p16)
  Adenocarcinoma Lung
FGFR3/TACC3
t(4;4)(p16;p16)

Zhang et al 2013, Nat Genet
  Astrocytoma, pilocytic/juvenile Brain
FGFR3/TACC3
t(4;4)(p16;p16)

Zhao et al 2017, Oncotarget
  Adenocarcinoma Prostate
SPON2/CTBP1
t(4;4)(p16;p16)